ROVI.MCROVI.MCBME
Loading
EPS Growth Under PressureDecelerating
Percentile Rank28
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P28
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -26.55% |
| Q3 2025 | 169.05% |
| Q2 2025 | 20.00% |
| Q1 2025 | -80.66% |
| Q4 2024 | 39.23% |
| Q3 2024 | 136.36% |
| Q2 2024 | 89.66% |
| Q1 2024 | -70.71% |
| Q4 2023 | 1.02% |
| Q3 2023 | 172.22% |
| Q2 2023 | -59.55% |
| Q1 2023 | -39.04% |
| Q4 2022 | 82.50% |
| Q3 2022 | 53.85% |
| Q2 2022 | -46.94% |
| Q1 2022 | -2.00% |
| Q4 2021 | 12.36% |
| Q3 2021 | 78.00% |
| Q2 2021 | 16.28% |
| Q1 2021 | 65.38% |
| Q4 2020 | -16.13% |
| Q3 2020 | 10.71% |
| Q2 2020 | 12.00% |
| Q1 2020 | 56.25% |
| Q4 2019 | -38.46% |
| Q3 2019 | 52.94% |
| Q2 2019 | 41.67% |
| Q1 2019 | 192.68% |
| Q4 2018 | -72.67% |
| Q3 2018 | 1053.85% |
| Q2 2018 | -90.71% |
| Q1 2018 | 3011.11% |
| Q4 2017 | -82.69% |
| Q3 2017 | -86.32% |
| Q2 2017 | 46.15% |
| Q1 2017 | 39.78% |
| Q4 2016 | 30.99% |
| Q3 2016 | -58.24% |
| Q2 2016 | -10.53% |
| Q1 2016 | 183.58% |